Safety Profile of Extended-Release Niacin in the AIM-HIGH Trial

被引:65
作者
Anderson, Todd J. [1 ]
Boden, William E. [2 ]
Desvigne-Nickens, Patrice [3 ]
Fleg, Jerome L. [3 ]
Kashyap, Moti L. [4 ]
McBride, Ruth [5 ]
Probstfield, Jeffrey L. [6 ]
机构
[1] Libin Cardiovasc Inst, Calgary, AB, Canada
[2] Albany Stratton Vet Affairs VA Med Ctr, Albany, NY USA
[3] NHLBI, Bethesda, MD 20892 USA
[4] VA Long Beach Healthcare Syst, Long Beach, CA USA
[5] Axio Res, Seattle, WA USA
[6] Univ Washington, Seattle, WA 98195 USA
关键词
D O I
10.1056/NEJMc1311039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:288 / 290
页数:3
相关论文
共 5 条
[1]  
Armitage Jane, HPS2 THRIVE RANDOMIZ
[2]   Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy [J].
Boden, William E. ;
Probstfield, Jeffrey L. ;
Anderson, Todd ;
Chaitman, Bernard R. ;
Desvignes-Nickens, Patrice ;
Koprowicz, Kent ;
McBride, Ruth ;
Teo, Koon ;
Weintraub, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) :2255-2267
[3]   HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment [J].
Haynes, Richard ;
Jiang, Lixin ;
Hopewell, Jemma C. ;
Li, Jing ;
Chen, Fang ;
Parish, Sarah ;
Landray, Martin J. ;
Collins, Rory ;
Armitage, Jane .
EUROPEAN HEART JOURNAL, 2013, 34 (17) :1279-1291
[4]   Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients [J].
Landray, Martin J. ;
Haynes, Richard ;
Hopewell, Jemma C. ;
Parish, Sarah ;
Aung, Theingi ;
Tomson, Joseph ;
Wallendszus, Karl ;
Craig, Martin ;
Jiang, Lixin ;
Collins, Rory ;
Armitage, Jane .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (03) :203-212
[5]  
The AIM-HIGH Investigators, 2012, NEW ENGL J MED, V367, P189